Litcius/Paper detail

Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-<i>d</i>]pyrimidines targeting VEGFR-2

Souad A. El‐Metwally, Hazem Elkady, Mohamed Hagras, Dalal Z. Husein, Ibrahim M. Ibrahim, Mohammed S. Taghour, Hesham A. El‐Mahdy, Ahmed Ismail, Bshra A. Alsfouk, Eslam B. Elkaeed, Ahmed M. Metwaly, Ibrahim H. Eissa

2023RSC Advances16 citationsDOIOpen Access PDF

Abstract

]pyrimidine derivatives as a new class of anticancer agents and provides a foundation for further research in this area.

Topics & Concepts

PyrimidineDocking (animal)ChemistryMolecular dynamicsApoptosisCell cycleIn vitroIC50Cancer cellStereochemistryCell cycle checkpointCancer researchBiophysicsBiochemistryCancerBiologyComputational chemistryGeneticsMedicineNursingBioactive Compounds and Antitumor AgentsSynthesis and biological activityCancer Mechanisms and Therapy
Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-<i>d</i>]pyrimidines targeting VEGFR-2 | Litcius